Search Results - "Etienne, I."

Individualized Mycophenolate Mofetil Dosing Based on Drug Exposure Significantly Improves Patient Outcomes After Renal Transplantation by Le Meur, Y., Büchler, M., Thierry, A., Caillard, S., Villemain, F., Lavaud, S., Etienne, I., Westeel, P.‐F., De Ligny, B. H., Rostaing, L., Thervet, E., Szelag, J. C., Rérolle, J.‐P., Rousseau, A., Touchard, G., Marquet, P.

“…Efficacy and safety of mycophenolate mofetil (MMF) may be optimized with individualized doses based on therapeutic monitoring of its active metabolite,…”
Get full text

Effect of extraction conditions on the yield, purity and surface properties of sugar beet pulp pectin extracts by Yapo, B.M., Robert, C., Etienne, I., Wathelet, B., Paquot, M.

“…The extraction of pectins from sugar beet pulp was carried out in an aqueous acid medium under different conditions using a full two-state experimental design…”
Get full text

Long‐Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 Genotype by Pallet, N., Etienne, I., Buchler, M., Bailly, E., Hurault de Ligny, B., Choukroun, G., Colosio, C., Thierry, A., Vigneau, C., Moulin, B., Le Meur, Y., Heng, A.‐E., Legendre, C., Beaune, P., Loriot, M. A., Thervet, E.

“…Pretransplantation adaptation of the daily dose of tacrolimus to CYP3A5 genotype is associated with improved achievement of target trough concentration (C0),…”
Get full text

Kidney Transplant Recipients Carrying the CYP3A422 Allelic Variant Have Reduced Tacrolimus Clearance and Often Reach Supratherapeutic Tacrolimus Concentrations by Pallet, N., Jannot, A.‐S., El Bahri, M., Etienne, I., Buchler, M., de Ligny, B. H., Choukroun, G., Colosio, C., Thierry, A., Vigneau, C., Moulin, B., Le Meur, Y., Heng, A.‐E., Subra, J.‐F., Legendre, C., Beaune, P., Alberti, C., Loriot, M. A., Thervet, E.

“…CYP3A4*22 is an allelic variant of the cytochrome P450 3A4 associated with a decreased activity. Carriers of this polymorphism may require reduced tacrolimus…”
Get full text

Diabetes-related quality of life in six European countries measured with the DOQ-30 by Pilv, Liina, Vermeire, Etienne I. J. J., Rätsep, Anneli, Moreau, Alain, Petek, Davorina, Yaman, Hakan, Oona, Marje, Kalda, Ruth

“…The quantification of diabetes-related quality of life (DR-QoL) is an essential step in making Type 2 Diabetes (T2DM) self-management arrangements. The…”
Get full text

Culture-Based Methods and Molecular Tools for Azole-Resistant Aspergillus fumigatus Detection in a Belgian University Hospital by Montesinos, I, Argudín, M A, Hites, M, Ahajjam, F, Dodémont, M, Dagyaran, C, Bakkali, M, Etienne, I, Jacobs, F, Knoop, C, Patteet, S, Lagrou, K

“…Azole-resistant is an increasing worldwide problem with major clinical implications. Surveillance is warranted to guide clinicians to provide optimal treatment…”
Get full text

Efficacy on Renal Function of Early Conversion from Cyclosporine to Sirolimus 3 Months After Renal Transplantation: Concept Study by Lebranchu, Y., Thierry, A., Toupance, O., Westeel, P. F., Etienne, I., Thervet, E., Moulin, B., Frouget, T., Le Meur, Y., Glotz, D., Heng, A‐E., Onno, C., Buchler, M., Girardot‐Seguin, S., De Ligny, B. Hurault

“…Sirolimus (SRL) allows to minimize the use of cyclosporine (CsA), but de novo administration after transplantation is associated with various complications. We…”
Get full text

Belatacept Rescue Therapy in Kidney Transplant Recipients With Vascular Lesions: A Case Control Study by Bertrand, D., Cheddani, L., Etienne, I., François, A., Hanoy, M., Laurent, C., Lebourg, L., Le Roy, F., Lelandais, L., Loron, M. C., Godin, M., Guerrot, D.

“…Immunosuppression in kidney transplant recipients with decreased graft function and severe histological vascular changes can be particularly challenging…”
Get full text

Predictive Modeling of Tacrolimus Dose Requirement Based on High‐Throughput Genetic Screening by Damon, C., Luck, M., Toullec, L., Etienne, I., Buchler, M., Hurault de Ligny, B., Choukroun, G., Thierry, A., Vigneau, C., Moulin, B., Heng, A.‐E., Subra, J.‐F., Legendre, C., Monnot, A., Yartseva, A., Bateson, M., Laurent‐Puig, P., Anglicheau, D., Beaune, P., Loriot, M. A., Thervet, E., Pallet, N.

“…Any biochemical reaction underlying drug metabolism depends on individual gene–drug interactions and on groups of genes interacting together. Based on a…”
Get full text

Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF—Four‐Year Results of the Postconcept Study by Lebranchu, Y., Thierry, A., Thervet, E., Büchler, M., Etienne, I., Westeel, P. F., de Ligny, B. Hurault, Moulin, B., Rérolle, J. P., Frouget, T., Girardot‐Seguin, S., Toupance, O.

“…Calcineurin inhibitor (CNI) withdrawal has been used as a strategy to improve renal allograft function. We previously reported that conversion from…”
Get full text

Electronic structure calculations for rhenium carbonitride: an extended Hückel tight-binding study by Palos, Etienne I, Paez, José I, Reyes-Serrato, Armando, Galván, Donald H

“…Effective theoretical models are needed to predict the physical properties of materials. Here we discuss the electronic structure of rhenium carbonitride…”
Get full text

Posterior vitreous detachment: more a case of the fibronectin interface than the inner limiting membrane? by Etienne, I., Jonckx, B., Feyen, J.

“…Purpose Use the periodic acid shift and immunohistochemical staining to visualize the distribution of the inner limiting membrane components on eyes presenting…”
Get full text

Immunosuppressant Regimen Based on Sirolimus Decreases Aortic Stiffness in Renal Transplant Recipients in Comparison to Cyclosporine by Joannidès, R., Monteil, C., de Ligny, B. H., Westeel, P. F., Iacob, M., Thervet, E., Barbier, S., Bellien, J., Lebranchu, Y., Seguin, S. G., Thuillez, C., Godin, M., Etienne, I.

“…Whether or not a cyclosporine A (CsA)‐free immunosuppressant regimen based on sirolimus (SRL) prevents aortic stiffening and improves central hemodynamics in…”
Get full text

Five‐Year Results of a Randomized Trial Comparing De Novo Sirolimus and Cyclosporine in Renal Transplantation: The Spiesser Study by Lebranchu, Y., Snanoudj, R., Toupance, O., Weestel, P.‐F., de Ligny, B. Hurault, Buchler, M., Rerolle, J.‐P., Thierry, A., Moulin, B., Subra, J.‐F., Deteix, P., Pogamp, P. Le, Finzi, L., Etienne, I.

“…Calcineurin inhibitors improve acute rejection rates and short‐term graft survival in renal transplantation, but their continuous use may be deleterious. We…”
Get full text

Antithymocyte globulin-induced hemolytic anemia and thrombocytopenia after kidney transplantation by Nattes, T de, Lelandais, Etienne, Laurent, Guerrot, Bertrand

“…Antithymocyte globulin is the most widely used lymphocyte-depleting treatment in kidney transplantation. In spite of the frequency of side effects, including…”
Get full text

Interstitial Fibrosis Quantification in Renal Transplant Recipients Randomized to Continue Cyclosporine or Convert to Sirolimus by Servais, A., Meas‐Yedid, V., Toupance, O., Lebranchu, Y., Thierry, A., Moulin, B., Etienne, I., Presne, C., Hurault, De Ligny B., Le Pogamp, P., Le Meur, Y., Glotz, D., Hayem, C., Marin, J. C. Olivo, Thervet, E.

“…Conversion from cyclosporine (CsA) to sirolimus at week 12 after kidney transplantation is associated with a significant improvement in renal function. The aim…”
Get full text

323 Cytomegalovirus (CMV) primoinfection caused serious deterioration in 2 young CF fathers by Pirson, J, Etienne, I, Ruiz-Patino, M, Sokolow, Y, Knoop, C

“…CMV is a highly prevalent virus in the adult population (60–100%) and in healthy adults is usually asymptomatic or causes only a mild mononucleosis-like…”
Get full text

324 Thrombo-embolic disease in CF patients: Difficult to diagnose, difficult to treat by Pirson, J, Etienne, I, Ruiz-Patino, M, Sokolow, Y, Knoop, C

“…The diagnosis of thrombo-embolic disease in CF patients is often difficult because of overlapping symptoms/signs with CF lung disease. We, here, report on the…”
Get full text

Profile of pediatric Crohn's disease in Belgium by De Greef, E., Mahachie John, J.M., Hoffman, I., Smets, F., Van Biervliet, S., Scaillon, M., Hauser, B., Paquot, I., Alliet, P., Arts, W., Dewit, O., Peeters, H., Baert, F., D'Haens, G., Rahier, J.F., Etienne, I., Bauraind, O., Van Gossum, A., Vermeire, S., Fontaine, F., Muls, V., Louis, E., Van de Mierop, F., Coche, J.C., Van Steen, K., Veereman, G.

“…A Belgian registry for pediatric Crohn's disease, BELCRO, was created. This first report aims at describing disease presentation and phenotype and determining…”
Get full text

236 The once-daily tacrolimus extended-release formulation provides similar drug exposure in non-CF and CF lung transplant recipients when compared to the conventional twice-daily formulation by Etienne, I, Woillard, J.-B, Marquet, P, Estenne, M, Knoop, C, Monchaud, C

Get full text